FID-134: a hyaluronan-bisphosphonate macromolecular drug delivery system for intra-articular treatment of osteoarthritis with potential combined cartilage and subchondral bone targeting. (April 2019) - Pavan, M.; Barbera, C.; Galesso, D.; Secchieri, C.; Pluda, S.